Warner Chilcott (WCRX)

Add to Watchlists Create an Alert
20.00 -0.25  -1.23%   NASDAQ May 23, 4:58PM BATS Real time Currency in USD

Warner Chilcott Interest Expense:

65.00M for March 31, 2013
View Full Chart

Warner Chilcott Interest Expense Chart

    Warner Chilcott Historical Interest Expense Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 65.00M
    Dec. 31, 2012 57.00M
    Sept. 30, 2012 65.00M
    June 30, 2012 52.00M
    March 31, 2012 62.00M
    Dec. 31, 2011 57.00M
    Sept. 30, 2011 63.00M
    June 30, 2011 65.00M
    March 31, 2011 0.00
    Dec. 31, 2010 0.00
    Sept. 30, 2010 0.00
    June 30, 2010 0.00
    March 31, 2010 0.00
    Dec. 31, 2009 0.00
    Sept. 30, 2009 23.96M
    June 30, 2009 0.00
       
    March 31, 2009 18.08M
    Dec. 31, 2008 0.00
    Sept. 30, 2008 0.00
    June 30, 2008 0.00
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro

    About Interest Expense

    When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.

    A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.

    YCharts includes both operating interest expense and non-operating interest expense in our numbers.
    Learn More

    Get data for

    WCRX Interest Expense Benchmarks

    Companies
    Mylan 77.99M
    Actavis 54.50M
    Valeant Pharmaceuticals International 155.32M

    WCRX Interest Expense Rankings

    Overall 34th percentile
    5215 of 8006
    Sector 9th percentile
    622 of 686 in Healthcare
    Industry 8th percentile
    62 of 68 in Drug Manufacturers - Specialty & Generic

    WCRX Interest Expense Range, Past 5 Years

    Minimum 0.00 Jun 2008
    Maximum 65.00M Jun 2011
    Average 26.40M